Christian Rust
Krankenhaus Barmherzige Brüder · 97 works · 8,232 citations · h-index 41
Top works
- Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
- Hepatocyte apoptosis after bile duct ligation in the mouse involves Fas
- Budesonide Induces Remission More Effectively Than Prednisone in a Controlled Trial of Patients With Autoimmune Hepatitis
- Lysophosphatidic Acid Is a Potential Mediator of Cholestatic Pruritus
- Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis
- Hepatocyte apoptosis is a pathologic feature of human alcoholic hepatitis
- Apoptosis and liver disease
- The Bile Acid Taurochenodeoxycholate Activates a Phosphatidylinositol 3-Kinase-dependent Survival Signaling Cascade
- Genome-Wide Association Analysis in Primary Sclerosing Cholangitis
- Serum autotaxin is increased in pruritus of cholestasis, but not of other origin, and responds to therapeutic interventions
- Genome-wide association analysis in primary sclerosing cholangitis identifies two non-HLA susceptibility loci
- Free fatty acids repress small heterodimer partner (SHP) activation and adiponectin counteracts bile acid-induced liver injury in superobese patients with nonalcoholic steatohepatitis
- Liver mitochondrial membrane crosslinking and destruction in a rat model of Wilson disease
- Overlap syndromes among autoimmune liver diseases
- Extended analysis of a genome-wide association study in primary sclerosing cholangitis detects multiple novel risk loci
- A randomized trial of obeticholic acid monotherapy in patients with primary biliary cholangitis
- Genome-Wide Association Analysis in Primary Sclerosing Cholangitis And Ulcerative Colitis Identifies Risk Loci at Gpr35 And Tcf4
- PR3-ANCA-positive Necrotizing Multi-organ Vasculitis Following Cocaine Abuse
- High dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis is safe and effective
- The bile acid–activated phosphatidylinositol 3-kinase pathway inhibits Fas apoptosis upstream of bid in rodent hepatocytes